BioMarin Pharmaceutical, Inc. (BMRN)
51.81
-1.43
(-2.69%)
USD |
NASDAQ |
May 15, 16:00
51.74
-0.07
(-0.14%)
After-Hours: 20:00
BioMarin Pharmaceutical Total Liabilities (Quarterly) : 2.379B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.959B |
| Mirum Pharmaceuticals, Inc. | 648.42M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.591B |
| Shareholders Equity (Quarterly) | 6.212B |
| Debt to Equity Ratio | 0.2328 |
| Current Ratio | 5.806 |
| Net Debt Paydown Yield | -1.46% |